Papers for

chemical manufacturing planners

Papers whose findings have a practical use for this group, as judged from the abstract. Open a paper to read what it means in practice.

Multi-agent system accelerates drug discovery from start to finish

MADDIE: Multi-Agent Drug Discovery Engine

Abstract: Drug discovery remains a resource-intensive and time-consuming process, involving billions of dollars and a decade of development to advance a drug to market. While many in silico tools have accelerated this process, operating them still demands substantial time, effort, and expertise from medicinal chemists. Autonomous systems built on Large Language Models (LLMs) have emerged as a promising solution, yet current designs limit their performance. Existing single-agent systems scale poorly to long-horizon, multi-step, and realistic tasks, whereas multi-agent systems typically execute predefined workflows that cannot capture the iterative, non-linear nature of a real drug discovery campaign. Here, we present MADDIE, a multi-agent drug discovery engine. It comprises a central agent, Orchestrator, and four specialized worker agents: HitIdentifier, LeadOptimizer, Synthesizer, and Evaluator, each representing a critical step in a drug discovery campaign. Under Orchestrator's orchestration and coordination, these worker agents are composed into flexible workflows, enabling MADDIE to adapt its strategy and navigate the drug discovery pipeline end-to-end. Across 50 protein targets, MADDIE produces molecules satisfying key property requirements and their synthesis routes, outperforming existing agentic systems, generative models, and general-purpose LLMs by a wide margin. Our analysis reveals how these agents collaborate and that MADDIE can employ different strategies across targets to achieve the campaign's goal, while still being efficient in time and tokens. Together, they demonstrate MADDIE as a low-cost, effective, and efficient autonomous engine for accelerating drug discovery. Code and dataset is available via https://github.com/ninglab/MADDIE.

Mon 12 OctArtificial Intelligence
The gist
Finding new medicines usually takes a lot of time, money, and expert effort. The authors present MADDIE, a system with multiple AI agents, each responsible for a key step in drug discovery. These agents work together flexibly to design, optimize, synthesize, and test molecules. MADDIE performed well on 50 different protein targets, creating molecules that meet important criteria and outlining how to make them. It is more efficient and effective than previous single-agent or fixed-workflow approaches.
Open → 2610.16975v1

Molecular design improved by searching continuous synthesis routes space

Navigating Route Latent Space for Synthesizable Molecular Design

Abstract: Goal-directed molecular design has advanced rapidly, yet a substantial proportion of designed molecules remain difficult to synthesize in practice, limiting their real-world utility. Prior synthesizability-aware methods either project generated molecules back to synthesizable analogs that deviate from the intended target, or optimize directly in discrete synthesis spaces that lack a continuous landscape for efficient search. We argue that this limitation mainly comes from the search space rather than the optimizer. To address this, we propose RouteFlow, a framework that reformulates synthesizable molecular design as a search over a continuous route latent space, where each latent maps back to a complete synthesis route and synthesizability is inherently preserved. To navigate this space, we adopt reward-guided flow matching as an efficient sampler that steers toward high-property regions. Since reward optimization may push latents off the manifold of real synthesis routes, where decoding becomes unreliable, we further introduce a cycle-consistency mechanism to stabilize fine-tuning. Across 16 optimization tasks from Therapeutic Data Commons, RouteFlow achieves the best sample efficiency among synthesizability-aware baselines, with the best synthetic accessibility and the highest retrosynthesis success rate. Our results also confirm that the proposed cycle-consistency reliably keeps optimization on-manifold while improving target properties, supporting effective synthesizable molecular discovery.

Tue 6 OctArtificial IntelligenceComputational Engineering, Finance, and Science
The gist
Designing new molecules often hits a roadblock because many are hard to make in real life. The authors found that searching in the usual way misses the smooth paths that connect easy-to-make molecules. They created RouteFlow, a method that looks through a continuous space of possible synthesis plans, making sure the molecules can actually be built. This helps find molecules that are both useful and practical to produce.
Open → 2610.07560v1